» Articles » PMID: 28152006

Expression and Prognostic Significance of Zinc Fingers and Homeoboxes Family Members in Renal Cell Carcinoma

Overview
Journal PLoS One
Date 2017 Feb 3
PMID 28152006
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Zinc fingers and homeoboxes (ZHX) is a transcription repressor family that contains three members; ZHX1, ZHX2, and ZHX3. Although ZHX family members have been associated with the progression of cancer, their values as prognostic factors in cancer patients have been poorly examined. Renal cell carcinoma (RCC) is a highly heterogeneous, aggressive cancer that responds variably to treatment. Thus, prognostic molecular markers are required to evaluate disease progression and to improve the survival. In clear cell RCC (ccRCC), ZHX1 and ZHX3 expression were found to be down-regulated but ZHX2 was up-regulated, and the expressions of ZHX1 and ZHX3 were significantly associated with pathological stage. Furthermore, Kaplan-Meier and multivariate regression analysis showed that reduction in the mRNA expression of ZHX1 was associated with poorer survival. Taken together, the present study shows loss of ZHX1 is correlated with ccRCC progression and suggests it is an independent prognostic marker in ccRCC.

Citing Articles

ZHX3 interacts with CEBPB to repress hepatic gluconeogenic gene expression and uric acid secretion.

Tan W, Lim L, Afsha N, Chan G, Ching C, Oguz G PNAS Nexus. 2025; 4(2):pgae568.

PMID: 39990763 PMC: 11843648. DOI: 10.1093/pnasnexus/pgae568.


Relationship between ZHX2 Expression and VHL Gene Alteration in VHL-associated and Sporadic Hemangioblastomas of the Central Nervous System.

Kanno H, Nakahara K, Yamada S, Fujii S, Murata H, Yamamoto T J Kidney Cancer VHL. 2025; 11(4):39-47.

PMID: 39850947 PMC: 11756601. DOI: 10.15586/jkcvhl.v11i4.355.


Niemann-Pick C1-like 1 as a Prognostic Marker in Renal Cell Carcinoma: A Retrospective Cohort Study.

Kwon R, Kim H, Lee Y, Lee H, Lee S, Park E Life (Basel). 2024; 14(11).

PMID: 39598242 PMC: 11595514. DOI: 10.3390/life14111444.


Expression and prognostic significance of microsomal triglyceride transfer protein in brain tumors: a retrospective cohort study.

Son S, Lee H, Kim J, Kwon R Transl Cancer Res. 2024; 13(5):2282-2294.

PMID: 38881934 PMC: 11170499. DOI: 10.21037/tcr-23-2286.


Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma.

Zhang C, Zeng J, Ye C, Tian K, Xian Z Transl Cancer Res. 2024; 13(1):150-172.

PMID: 38410230 PMC: 10894348. DOI: 10.21037/tcr-23-1383.


References
1.
Pruitt H, Devine D, Samant R . Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination. Int J Cancer. 2016; 139(3):491-500. PMC: 5069610. DOI: 10.1002/ijc.30043. View

2.
Finley D, Pantuck A, Belldegrun A . Tumor biology and prognostic factors in renal cell carcinoma. Oncologist. 2011; 16 Suppl 2:4-13. PMC: 3868202. DOI: 10.1634/theoncologist.2011-S2-04. View

3.
Mignogna C, Staibano S, Altieri V, De Rosa G, Pannone G, Santoro A . Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. BMC Cancer. 2006; 6:293. PMC: 1766933. DOI: 10.1186/1471-2407-6-293. View

4.
Eichelberg C, Junker K, Ljungberg B, Moch H . Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol. 2009; 55(4):851-63. DOI: 10.1016/j.eururo.2009.01.003. View

5.
Vermassen T, De Meulenaere A, Van de Walle M, Rottey S . Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma. Acta Clin Belg. 2016; 72(1):12-18. DOI: 10.1080/17843286.2016.1193269. View